Evogene Ltd.
$0.55
+0.01 (+2.16%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +12.3%
- 3 Months
- -22.0%
- YTD
- -50.0%
- 1 Year
- -58.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 77.1%
- Largest decline max drawdown, since Aug 2025
- -73.4%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.75
Own EVGN?
See how EVGN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.